SCHEMBL25682486

SCHEMBL25682486

Cn1c2cc3c(cc2c2cccc(C(C)(C)C)c21)sc1ccccc13

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.38
▸ MAPT P10636 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PTPN7 P35236 1/20 0.36
▸ DUSP3 P51452 1/20 0.36
▸ PTPN12 Q05209 1/20 0.36
▸ PTPN22 Q9Y2R2 1/20 0.36
▸ ALKBH5 Q6P6C2 1/20 0.36
▸ FTO Q9C0B1 1/20 0.36
▸ APEX1 P27695 1/20 0.33
▸ PMM2 O15305 2/20 0.33
▸ MPI P34949 2/20 0.33
▸ PHOSPHO1 Q8TCT1 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25682688 0.95 GPR3 (0.38) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL25682515 0.83 GPR3 (0.37) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL12170784 0.82 GPR3 (0.52) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL25681791 0.80 HSD17B10 (0.38) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL25993611 0.80 GPR3 (0.37) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL25682487 0.80 KIF11 (0.49) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL25682488 0.80 KIF11 (0.42) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL25682547 0.79 GPR3 (0.41) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL25974762 0.79 ALKBH5 (0.40) GPR3MAPTALDH1A1HPGDALKBH5
SCHEMBL13183678 0.78 GPR3 (0.53) GPR3MAPTALDH1A1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 GPR3 1535/4885MAPT 1225/4885ALDH1A1 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback